Latin America Influenza Vaccines Market 2019-2028

MARKET OUTLOOK

As per an analysis, the influenza vaccines market in Latin America will grow at a CAGR of 6.49% in the forecasted period 2019-2028.
Brazil, Mexico and the Rest of Latin America together form the influenza vaccines market in Latin America.

The rising incidence of death among children, increasing incidences of influenza and the explosive growth in the geriatric population, are some of the major factors driving the growth of the influenza vaccines market in Latin America. The growing economy and the escalating private healthcare insurance employments in Brazil, to enhance the healthcare services, are anticipated to push the adoption of the influenza vaccines in the country. Besides, increasing access to different cost-efficient vaccines available is also boosting the market growth further in the region over the coming years.

In Brazil, mass immunization started in 1999, initially targeting about 11 million individuals in the country with 65 and above years of age. In 2000, this age limit was changed as 60 years old. Such national immunization campaigns reported achieving a vaccination coverage rate between 71.8% and 87.3%. The success of the PNI (Brazilian National Immunization Program) for infant recommended vaccination is also attributing to the growing demand for the influenza vaccines market in the country. Therefore, this will aid the growth of the studied market in detail.

COMPETITIVE OUTLOOK

Some of the major players in the influenza vaccines market are CSL Limited, BioDiem, Sanofi, Abbott and GlaxoSmithKline Plc.

1. Latin America Influenza Vaccines Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Quadrivalent is the Dominant Type of Influenza Vaccine
2.2.2. Injection is Fastest-Growing Delivery Mode
2.2.3. Cell-Based Technology is Rapidly Growing Technology in the Market
2.2.4. Adult Age Group is Majorly Contributing in the Market
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Intensity of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Advancement in Technology
2.6.2. Initiatives Taken Up by the Government
2.7. Market Restraints
2.7.1. High Cost of Development
2.8. Market Opportunities
2.8.1. Growth in the Cases of Influenza
2.9. Market Challenges
2.9.1. Complex Development Process

3. Influenza Vaccines Market Outlook - by Type

3.1. Quadrivalent Vaccine
3.2. Trivalent Vaccine

4. Influenza Vaccines Market Outlook - by Technology

4.1. Egg-Based Technology
4.2. Cell-Based Technology

5. Influenza Vaccines Market Outlook - by Age Group

5.1. Pediatric Age Group
5.2. Adult Age Group

6. Influenza Vaccines Market Outlook - by Delivery Mode

6.1. Injection
6.2. Nasal Spray

7. Influenza Vaccines Market – Latin America

7.1. Brazil
7.2. Mexico
7.3. Rest of Latin America

8. Competitive Landscape

8.1. Merck Sharp & Dohme Corp
8.2. Novartis AG
8.3. Pfizer Inc
8.4. Sanofi
8.5. Biodiem
8.6. Emergent Biosolutions Inc
8.7. F. Hoffmann-La Roche Ltd
8.8. GlaxoSmithKline plc
8.9. Abbott
8.10. CSL Limited

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1: Latin America Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Latin America Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 4: Latin America Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 5: Latin America Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 6: Latin America Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 7: Latin America Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)

List of Figures

Figure 1: Latin America Influenza Vaccines Market, by Source, 2019 & 2028 (In %)
Figure 2: Latin America Quadrivalent Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 3: Latin America Injection Delivery Model Market, 2019-2028 (In $ Million)
Figure 4: Latin America Cell Based Technology Market, 2019-2028 (In $ Million)
Figure 5: Latin America Adult Age Group Market, 2019-2028 (In $ Million)
Figure 6: Porter's Five Force Analysis
Figure 7: Market Attractiveness Index
Figure 8: Latin America Influenza Vaccines Market, by Quadrivalent Vaccine, 2019-2028 (In $ Million)
Figure 9: Latin America Influenza Vaccines Market, by Trivalent Vaccines, 2019-2028 (In $ Million)
Figure 10: Latin America Influenza Vaccines Market, by Egg-Based Technology, 2019-2028 (In $ Million)
Figure 11: Latin America Influenza Vaccines Market, by Cell-Based Technology, 2019-2028 (In $ Million)
Figure 12: Latin America Influenza Vaccines Market, by Pediatric Age Group, 2019-2028 (In $ Million)
Figure 13: Latin America Influenza Vaccines Market, by Adult Age Group, 2019-2028 (In $ Million)
Figure 14: Latin America Influenza Vaccines Market, by Injection, 2019-2028 (In $ Million)
Figure 15: Latin America Influenza Vaccines Market, by Nasal Spray, 2019-2028 (In $ Million)
Figure 16: Latin America Influenza Vaccines Market, Regional Outlook, 2019 & 2028 (In %)
Figure 17: Brazil Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 18: Mexico Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 19: Rest of Latin America Influenza Vaccines Market, 2019-2028 (In $ Million)